My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Cardiovascular complications in diabetes: targets and interventions.

    Stirban AO, Tschoepe D.

    Diabetes Care. 2008 Feb;31 Suppl 2:S215-21. Review.PMID: 18227488 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Primary prevention of cardiovascular disease in people with dysglycemia.

    Bianchi C, Miccoli R, Penno G, Del Prato S.

    Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. Review.PMID: 18227487 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.

    Yamagishi S, Nakamura K, Takeuchi M, Imaizumi T.

    Int J Clin Pharmacol Res. 2004;24(4):129-34. Review.PMID: 15754918 [PubMed - indexed for MEDLINE]Related articles

    4.

    Screening for coronary artery disease in patients with diabetes.

    Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ; ADA.

    Diabetes Care. 2007 Oct;30(10):2729-36.PMID: 17901530 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.

    Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M.

    Diabetes Care. 2008 Feb;31 Suppl 2:S155-60. Review.PMID: 18227478 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease.

    Yamagishi S, Nakamura K, Matsui T, Ueda S, Noda Y, Imaizumi T.

    Cardiovasc Ther. 2008 Spring;26(1):50-8. Review.PMID: 18466420 [PubMed - indexed for MEDLINE]Related articles

    7.

    Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease.

    Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G, Ballantyne CM, Cannon CP.

    Am Heart J. 2008 Oct;156(4):719-27. Epub 2008 Jul 11.PMID: 18926153 [PubMed - indexed for MEDLINE]Related articles

    8.

    Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes.

    Yamagishi S, Matsui T, Ueda S, Nakamura K, Imaizumi T.

    Cardiovasc Hematol Agents Med Chem. 2007 Jul;5(3):236-40. Review.PMID: 17630950 [PubMed - indexed for MEDLINE]Related articles

    9.

    Advanced glycation end products and vascular structure and function.

    Soldatos G, Cooper ME.

    Curr Hypertens Rep. 2006 Dec;8(6):472-8. Review.PMID: 17087858 [PubMed - indexed for MEDLINE]Related articles

    10.

    Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?

    Stirban AO, Tschoepe D.

    Diabetes Care. 2008 Feb;31 Suppl 2:S226-8.PMID: 18227490 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Macronutrients, advanced glycation end products, and vascular reactivity.

    Dandona P, Chaudhuri A, Mohanty P.

    Diabetes Care. 2007 Oct;30(10):2750-1. No abstract available. PMID: 17901533 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cardiovascular disease in diabetes.

    Yamagishi S, Nakamura K, Matsui T, Takenaka K, Jinnouchi Y, Imaizumi T.

    Mini Rev Med Chem. 2006 Mar;6(3):313-8. Review.PMID: 16515470 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hypertension and diabetes.

    Grossman E, Messerli FH.

    Adv Cardiol. 2008;45:82-106. Review.PMID: 18230957 [PubMed - indexed for MEDLINE]Related articles

    14.

    The diabetes epidemic: a national and global crisis.

    Bonow RO, Gheorghiade M.

    Am J Med. 2004 Mar 8;116 Suppl 5A:2S-10S. Review.PMID: 15019858 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Long-term intervention studies of diabetic macroangiopathy in Japan and western countries]

    Sone H, Yamada N.

    Nippon Rinsho. 2006 Nov;64(11):2021-30. Review. Japanese. PMID: 17087292 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?

    Renard C, Van Obberghen E.

    Diabetes Metab. 2006 Feb;32(1):15-29. Review.PMID: 16523183 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Advanced glycation end products (AGEs) and diabetic vascular complications.

    Yamagishi S, Nakamura K, Imaizumi T.

    Curr Diabetes Rev. 2005 Feb;1(1):93-106. Review.PMID: 18220586 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation]

    Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian. PMID: 18773746 [PubMed - indexed for MEDLINE]Related articles

    19.

    Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

    Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

    Diabetes Care. 2007 Jan;30(1):162-72. Review.PMID: 17192355 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Hyperglycemia and the pathobiology of diabetic complications.

    Aronson D.

    Adv Cardiol. 2008;45:1-16. Review.PMID: 18230953 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity